Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/1999
03/18/1999WO1999012531A2 Hormonal contraceptive
03/18/1999WO1999012521A1 New foam-forming pharmaceutical composition
03/18/1999WO1998058954A3 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
03/18/1999DE19739916A1 Mittel zur hormonalen Kontrazeption Means for hormonal contraception
03/18/1999CA2569685A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999CA2302710A1 New foam-forming pharmaceutical composition
03/17/1999EP0902022A1 Novel benzofuranone derivatives and process for producing the same
03/17/1999EP0902018A2 2-(Arylphenyl)amino-imidazoline derivatives
03/17/1999EP0901489A1 Antagonists of gonadotropin releasing hormone
03/17/1999EP0901474A1 Aryl pyrimidine derivatives
03/17/1999EP0901470A1 Indole derivatives useful as endothelin receptor antagonists
03/17/1999EP0831858A4 Intrauterine chemical necrosing method and composition
03/17/1999EP0655058B1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
03/17/1999EP0616536B1 Use of decorin or biglycan for the manufacture of a medicament in the treatment of diabetes-associated pathology
03/17/1999EP0565634B1 Angiotensin ii receptor blocking compositions
03/17/1999CN1211238A Benzimidazole derivatives
03/17/1999CN1211193A Contraceptive release systems with antibacterial and/or antiviral effect
03/17/1999CN1211189A Urogenital and intestinal disorder compositions comprising a substrance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
03/17/1999CN1211188A Urogenital and intestinal compositions
03/17/1999CN1210727A Chinese drugs for curing male sexual dys-function and its preparing technology
03/16/1999US5883133 Cardiovascular disorders
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883118 Anticarcinogenic agents
03/16/1999US5883090 Endothelin receptor antagonists
03/16/1999US5883075 Hypotensive agent cyclic peptides
03/16/1999CA2244232A1 Novel def
03/16/1999CA2165012C Estrogen agonists
03/16/1999CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999WO1999011288A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction
03/11/1999WO1999011286A1 Vaginal suppository vaccine for urogenital infections
03/11/1999WO1999011282A1 Compositions and methods for contraception in or sterilization of mammals
03/11/1999CA2302505A1 Vaginal suppository vaccine for urogenital infections
03/11/1999CA2302403A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/10/1999EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900221A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
03/10/1999EP0900201A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
03/10/1999EP0494158B1 A recombinant birth control vaccine
03/09/1999US5880267 Trophinin and trophinin-assisting protein agonists, antibodies and antagonists
03/09/1999US5880093 Useful in prevention of spontaneous abortion and premature labor
03/09/1999US5879908 CRFG-1a, a target and marker for chronic renal failure
03/09/1999US5879877 Separating motile sperm
03/04/1999WO1999010364A1 Follistatin-3
03/04/1999WO1999010363A1 29 human secreted proteins
03/04/1999WO1999010330A1 Heterocyclic ketones as npy y5 antagonists
03/04/1999WO1999009993A1 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
03/04/1999WO1999009964A2 Pharmaceutical composition containing clindamycin and clotrimazol for treating vaginal infections
03/04/1999DE19737348A1 Neue pharmazeutische Zusammensetzung New pharmaceutical composition
03/04/1999CA2302525A1 Follistatin-3
03/04/1999CA2302387A1 29 human secreted proteins
03/04/1999CA2301821A1 Heterocyclic ketones as npy y5 antagonists
03/04/1999CA2245755A1 2-(arylphenyl)amino-imidazoline derivatives
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
03/03/1999EP0898478A1 Stimulation of host defence mechanisms against tumors
03/03/1999EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
03/03/1999CN1209750A Combined pharmaceutical preparation containing LHRH-analogous substances and anti-estrogens for treating gynaecological disorders
03/03/1999CN1209455A DNA of encoding plasminogen excited protein
03/03/1999CN1209319A Preparation method for medicinal composition containing aza-steroid compound for treating prostatic hyperplasia
03/03/1999CN1209315A Improvement of auxiliary material containing chlorohaxanpyridine acetate
03/03/1999CN1042296C Preparation method for medicinal preparation for contraception
03/02/1999US5877016 Human trk receptors and neurotrophic factor inhibitors
03/02/1999US5876746 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
03/02/1999US5876730 Heparin-binding growth factor (HBGF) polypeptides
02/1999
02/25/1999WO1999009168A1 Testis-specific transcription factor zgcl-1
02/25/1999WO1999009024A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists
02/25/1999CA2301043A1 Testis-specific transcription factor zgcl-1
02/25/1999CA2300178A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists
02/24/1999EP0703904B1 Pyrimidine cyanoguanidines as k-channel blockers
02/24/1999CN1209129A Antagonists of gonadotropin releasing hormone
02/24/1999CN1209120A 17-side chain ankynyl-and 20-oxopregna-derivatives of vitamin D, prodn. and pharmaceutical composition thereof
02/24/1999CN1208621A Traditional Chinese medicine capsule 'Taibao'
02/24/1999CN1042226C Heterocyclic derivatives and method for preparing the salt thereof
02/23/1999US5874535 Human leptin receptor gene-related protein
02/23/1999US5874437 Impotence
02/23/1999US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor
02/23/1999US5874245 Human G-protein coupled receptor (HIBCD07)
02/23/1999CA1340401C Cell surface protein, process for its preparation, and the use of a cell surface protein thus obtained
02/18/1999WO1999007856A1 Novel metalloprotease
02/18/1999WO1999007740A2 Lipocalin homologs
02/18/1999WO1999007407A1 Heparin-binding growth factor (hbgf) polypeptides
02/18/1999WO1999007396A1 Composition comprising propolis and at least an essential oil
02/18/1999CA2301068A1 Composition comprising propolis and at least an essential oil
02/18/1999CA2299411A1 Heparin-binding growth factor (hbgf) polypeptides
02/18/1999CA2298439A1 Lipocalin homologs
02/18/1999CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
02/17/1999EP0896822A1 4-Aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
02/17/1999EP0896582A1 Non-dendritic backbone peptide carrier
02/17/1999CN1208418A Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
02/17/1999CN1208417A Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
02/17/1999CN1208413A Antagonists of gonadotropin releasing hormone
02/17/1999CN1208412A Antagonists of gonadotropin releasing hormone
02/17/1999CN1208034A Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
02/16/1999US5872119 2-Naphthamide derivatives and their therapeutic applications
02/16/1999US5872114 Therapeutic methods and delivery systems utilizing sex steroid precursors
02/16/1999US5872107 Anticarcinogenic agents capture therapy for tumors
02/16/1999CA1340397C Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception
02/15/1999CA2224096A1 The g-protein coupled receptor hfia041
1 ... 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 ... 557